首页 | 本学科首页   官方微博 | 高级检索  
     

糖尿病合并慢性心力衰竭患者检测糖化血红蛋白和BNP的临床意义探讨
引用本文:高树. 糖尿病合并慢性心力衰竭患者检测糖化血红蛋白和BNP的临床意义探讨[J]. 中国现代药物应用, 2021, 0(2): 19-21
作者姓名:高树
作者单位:辽宁省抚顺市三院
摘    要:目的 探讨糖化血红蛋白和脑钠肽(BNP)检测对糖尿病合并慢性心力衰竭患者的临床意义.方法 选取60例糖尿病合并慢性心力衰竭患者作为观察组,另选取同期60例糖尿病未合并慢性心力衰竭患者作为对照组.比较两组患者的糖化血红蛋白及BNP水平;观察组不同心功能分级患者的糖化血红蛋白及BNP水平;随访1年,比较两组患者的心脏不良事...

关 键 词:糖尿病  慢性心力衰竭  糖化血红蛋白  脑钠肽

Clinical significance of detection of glycosylated hemoglobin and BNP in patients with diabetes mellitus complicated with chronic heart failure
GAO Shu. Clinical significance of detection of glycosylated hemoglobin and BNP in patients with diabetes mellitus complicated with chronic heart failure[J]. Chinese Journal of Modern Drug Application, 2021, 0(2): 19-21
Authors:GAO Shu
Affiliation:(Fushun Third Hospital,Fushun 113006,China)
Abstract:Objective To discuss the clinical significance of detection of glycosylated hemoglobin and brain natriuretic peptide(BNP)in patients with diabetes mellitus complicated with chronic heart failure.Methods There were 60 patients with diabetes mellitus complicated with chronic heart failure selected as the observation group,and 60 diabetes mellitus patients without chronic heart failure during the same period as the control group.Comparison was made on levels of glycosylated hemoglobin and BNP,and occurrence of adverse cardiac events after 1 year of follow-up between the two groups,levels of glycosylated hemoglobin and BNP in patients with different cardiac function grades in observation group.Results The glycosylated hemoglobin and BNP of the observation group were(10.3±2.3)%and(937.1±10.9)pg/ml,which were obviously higher than(8.1±2.2)%and(190.3±8.4)pg/ml of the control group,and the difference was statistically significant(P<0.05).There was no statistically significant in levels of glycosylated hemoglobin and BNP in patients with different cardiac function grades in the observation group(P<0.05).With the increase of cardiac function classification,the levels of glycosylated hemoglobin and BNP increased.The incidence of adverse cardiac events of the observation group was 41.7%,which was higher than 20.0%of the control group,and the difference was statistically significant(P<0.05).Conclusion Monitoring glycosylated hemoglobin and BNP in patients with diabetes and chronic heart failure can provide a better assessment of the patient's condition and prognosis,and play an important role in preventing adverse cardiac events.
Keywords:Diabetes mellitus  Chronic heart failure  Glycosylated hemoglobin  Brain natriuretic peptide
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号